Jazz Pharmaceuticals Joins The Movement For Awareness And Support On World Cancer Day With The Upside Down Challenge

2025-02-06 11:00:23

(MENAFN- 3BL) It is estimated that about 1 in 5 people will develop cancer in their lifetime. Receiving a cancer diagnosis can feel like your life, and the lives of those around you, have been flipped upside down.
In honor of #WorldCancerDay , we're participating in the Union for International Cancer Control (UICC) 's Upside Down Challenge to rally behind the unique voices of every patient and family member impacted by cancer and help bring much-needed awareness to this challenging disease.
Learn how you can get involved today and use the hashtag #UnitedByUnique

About Jazz Pharmaceuticals

Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing potentially life-changing medicines for people with serious diseases - often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit for more information.

MENAFN06022025007202015466ID1109179005

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.